New articles

09.12.2025

Adipocytes and the role of their hormonal activity in the development of obesity

Shishkina V. V., Glukhov A. A., Andreev A. A., Kovalenko N. S., Eliseev M. V., Laptiyova A. Yu., Ostroushko A. P., Frolov A. Yu.
10.14341/omet13149
In the world, more than 2 billion people are overweight, which makes up 30-39% of the world’s population. Against the background of existing obesity, ...
09.12.2025

Cardiorehabilitation of metabolic syndrome in the aftermath of the COVID-19 pandemic

Avdeeva K. S., Petelina T. I., Gorbachevskii A. V., Sharoyan Yu. A., Redkina I. N.
10.14341/omet13203
Metabolic syndrome-related diseases account for two-thirds of non-communicable disease deaths, most of which may begin early in life. The pro-inflamma...
09.12.2025

Arterial hypertension in young patients with type 1 diabetes mellitus. Dysbiosis and increased paracellular intestinal permeability as potential links of pathogenesis

Useinova R. Kh., Beloglazov V. A., Repinskaya I. N., Yatskov I. A.
10.14341/omet13137
The incidence of type 1 diabetes is increasing worldwide, especially among young patients. This trend is very unfavorable, since the risk of death of ...
09.12.2025

Genomic imprinting disorders in the structure of syndromic obesity in children

Vasyukova O. V., Atavina-Ermakova E. P., Panchenko E. G., Kopytina D. A., Simonova O. A., Udalova V. Y., Kanivets I. V., Akimova D. B., Skoblov M. Y., Andreeva M. A., Nagaeva E. V., Mokrysheva N. G.
10.14341/omet13276
BACKGROUND. Genomic imprinting disorders represent a distinct class of hereditary diseases caused by disruption of the monoallelic expression of impri...
09.12.2025

Long-term dynamics of the prevalence of childhood and adolescent obesity in Russia and the world

Alferova V. I., Mustafina S. V.
10.14341/omet13200
This review analyzes the prevalence of childhood and adolescent obesity in the Russian Federation. Data from various regional studies are provided. In...
09.12.2025

Metabolic effects of GABA derivatives and their combined use with sitagliptin in experimental obesity

Tyurenkov I. N., Bakulin D. A., Sokolova A. A., Smirnov A. V., Batsunov A. I., Bolokhov N. S., Velikorodnaya Yu. I., Vasilyeva O. S., Makarenko S. V.
10.14341/omet13114
BACKGROUND: The increase in the number of people with obesity is associated with an increase in the prevalence of cardiovascular diseases, justifying ...
09.12.2025

Effectiveness and safety of varying intensity physical training in obese patients

Lelyavina T. A., Galagudza M. M., Babenko A. Y., Sonin D. L., Markina N. O., Stein K. A., Shlyakhto E. V.
10.14341/omet13156
AIM. To evaluate the effectiveness and safety of physical training of varying intensity in obese patients.METHODS. A single-center open-label randomiz...
09.12.2025

Gut microbiota metabolites and insulin resistance parameters as potential indicators of the development and progression of arterial hypertension

Petelina T. I., Avdeeva K. S., Valeeva L. L., Gorbachevskii A. V., Kapustina A. A., Gapon L. I.
10.14341/omet13212
BACKGROUND: The steady annual increase in publications in the field of gut microbiota (GM) and insulin resistance indicates a growing recognition of t...
09.12.2025

Primary Hyperparathyroidism and Cardiovascular Disease

Dobreva E. A., Tarasova E. V., Gorbacheva A. M., Bibik E. E., Bondarenko I. Z., Mokrysheva N. G.
10.14341/omet13273
Cardiovascular diseases (CVDs) have long been the leading cause of mortality and morbidity worldwide. It has been demonstrated that disturbances in ca...
09.12.2025

Pathophysiologic interrelationships of metabolic syndrome and gut microbiota

Klimchuk A. V., Kritskaya D. V., Ivashkova E. O., Konovalova P. S., Yatskov I. A.
10.14341/omet13097
The problem of obesity and metabolic syndrome is becoming increasingly global in the modern world. The social and environmental factors that play a ro...